1. Home
  2. Analysis
  3. Amlodipine-besylate
  4. Ticlid

Amlodipine besylate and Ticlid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 7 people who take Amlodipine besylate and Ticlid. Common interactions include horner's syndrome among females, and coronary artery occlusion among males.

The phase IV clinical study analyzes what interactions people who take Amlodipine besylate and Ticlid have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

7 people who take Amlodipine besylate and Ticlid together, and have interactions are studied.

What is Amlodipine besylate?

Amlodipine besylate has active ingredients of amlodipine besylate. It is used in high blood pressure. Currently, eHealthMe is studying from 67,917 Amlodipine besylate users.

What is Ticlid?

Ticlid has active ingredients of ticlopidine hydrochloride. Currently, eHealthMe is studying from 3,093 Ticlid users.

Number of Amlodipine besylate and Ticlid reports submitted per year:

Amlodipine besylate and Ticlid drug interactions.

Common Amlodipine Besylate and Ticlid drug interactions by gender *:

female:

  1. Horner's syndrome
  2. Squamous cell carcinoma
  3. Blood glucose increased
  4. Death
  5. Drug ineffective
  6. Fall
  7. General physical health deterioration
  8. Malignant neoplasm progression
  9. Middle insomnia
  10. Oedema

male:

  1. Coronary artery occlusion
  2. Arthralgia
  3. Pruritus
  4. Somnolence
  5. Stress
  6. Contusion
  7. Coronary revascularisation
  8. Cough
  9. Dyspnoea
  10. Erythema

Common Amlodipine Besylate and Ticlid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Coronary artery occlusion
  2. Coronary revascularisation
  3. Erythema
  4. Pruritus
  5. Somnolence
  6. Stress

60+:

  1. Arthralgia
  2. Blood glucose increased
  3. Horner's syndrome
  4. Interstitial lung disease
  5. Malignant neoplasm progression
  6. Middle insomnia
  7. Musculoskeletal stiffness
  8. Oedema
  9. Oedema peripheral
  10. Pneumonia

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine besylate and Ticlid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Amlodipine besylate drug interactions:

Browse interactions between Amlodipine besylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ticlid drug interactions:

Browse interactions between Ticlid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate and ticlopidine hydrochloride (the active ingredients of Amlodipine besylate and Ticlid, respectively), and Amlodipine besylate and Ticlid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Amlodipine besylate and Ticlid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.